Insider Trading History of Middlekauff W Bradford

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Middlekauff W Bradford since 2006. The trader's CIK number is 1214501. At the time of the last reporting, Middlekauff W Bradford was the SVP, General Counsel of Edge Therapeutics, Inc.. (stock ticker symbol EDGE). Also see all insider trading activities at Edge Therapeutics, Inc..

Note that in the past MIDDLEKAUFF W BRADFORD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Medarex Inc (MEDX) by Middlekauff W Bradford

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 MEDX 0 $0 16,328 $194,052 16,328 $0
2006 MEDX 0 $0 100,000 $1,388,000 100,000 $637,000

Yearly summary of insider trading at Edge Therapeutics, Inc. (EDGE) by Middlekauff W Bradford

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 EDGE 0 $0 0 $0 49,766 $0
2016 EDGE 10,000 $94,792 0 $0 0 $0


Insider trading activities at 2 companies by Middlekauff W Bradford:

1. Medarex Inc (MEDX)

2. Edge Therapeutics, Inc. (EDGE)

Table 1. Insider trading of Medarex Inc (MEDX) by Middlekauff W Bradford

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-03-16 MEDX Sale 5,450 11.91 64,909
2007-03-02 MEDX Option Ex 16,328 .00 0
2007-03-19 MEDX Sale 10,878 11.87 129,143
2006-03-17 MEDX Sale 100,000 13.88 1,388,000
2006-03-17 MEDX Option Ex 100,000 6.37 637,000

Table 2. Insider trading of Edge Therapeutics, Inc. (EDGE) by Middlekauff W Bradford

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-03-15 EDGE Option Ex 49,766 .00 0
2016-08-08 EDGE Buy 143 9.43 1,348
2016-08-05 EDGE Buy 9,857 9.48 93,444

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Middlekauff W Bradford (SVP, General Counsel of Edge Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.